Current Hematologic Malignancy Reports

期刊名

Current Hematologic Malignancy Reports

CURR HEMATOL MALIG R

ISSN / eISSN

1558-8211 / 1558-822X

目标和范围

his journal intends to provide clear, insightful, balanced contributions by international experts that review the most important, recently published clinical findings related to the diagnosis, treatment, management, and prevention of hematologic malignancy.

We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as leukemia, lymphoma, myeloma, and T-cell and other lymphoproliferative malignancies. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also provided.

研究方向

血液学

肿瘤学

CiteScore

6.80 查看趋势图

CiteScore 学科排名

类别	分区	排名
Medicine - Hematology	Q1	#30/129
Medicine - Oncology	Q2	#105/366
Medicine - Cancer Research	Q2	#92/214

Web of Science 核心合集

Science Citation Index Expanded (SCIE)	Social Sciences Citation Index (SSCI)
Indexed	-

类别 (Journal Citation Reports 2023)	分区
HEMATOLOGY - SCIE	Q3
ONCOLOGY - SCIE	Q3

H-index

28

出版国家或地区

UNITED STATES

出版商

Springer US

出版周期

6 issues per year

出版年份

2006

年文章数

29

Open Access

NO

通讯方式

400 MARKET STREET, STE 700, PHILADELPHIA, USA, PA, 19106